Fas counterattack in cholangiocarcinoma: A mechanism for immune evasion in human hilar cholangiocarcinomas

Figure 1 FasL positive in human hilar cholangiocarcinom as (brown). SABC × 200

Figure 2 Expression of FasL in cholangiocarcinoma cell line. QBC939 × 200

Figure 3 Expression of FasL mRNA in human cholangiocarcinoma cells QBC939. M: DL 2000 Marker; 1: FasL; 2: FasL+β-actin

Figure 4 CD45 positive cells (brown) of lymphoid morphology adjacent to carcinoma. × 200

Figure 5 Positive apoptotic TUNEL stainig in situ (brown) with apoptotic morphology.

Figure 6 Western blotting of FasL protein with mAb from QBC939 cell cultures clone 33 from QBC939 cell cultures